title: Antiangiogenic activity of chemopreventive drugs.
abstract: Tumors growing within the host form dynamic aberrant tissue that consists of host components, including the stroma, an expanding vasculature and often chronic inflammation, in addition to the tumor cells themselves. These host components can contribute to, rather than limit, tumor expansion, whereas deprivation of vessel formation has the potential to confine tumors in small, clinically silent foci. Therapeutic inhibition of vessel formation could be best suited to preventive strategies aimed at the suppression of angiogenesis in primary tumors in subjects at risk, or of micrometastases after surgical removal of a primary tumor. Our analysis of potential cancer chemopreventive molecules including N-acetylcysteine, green tea flavonoids and 4-hydroxyphenyl-retinamide has identified antiangiogenic activities that could account--at least in part--for the tumor prevention effects observed with these compounds. These drugs appear to target common mechanisms of tumor angiogenesis that may permit identification of critical targets for antiangiogenic therapy and antiangiogenic chemoprevention.
authors.affiliation: Laboratory of Molecular Oncology, National Cancer Research Institute, Genoa, Italy. ulrich.pfeffer@istge.it
authors.forename: U
authors.initials: U
authors.lastname: Pfeffer
authors.forename: N
authors.initials: N
authors.lastname: Ferrari
authors.forename: M
authors.initials: M
authors.lastname: Morini
authors.forename: R
authors.initials: R
authors.lastname: Benelli
authors.forename: D M
authors.initials: DM
authors.lastname: Noonan
authors.forename: A
authors.initials: A
authors.lastname: Albini
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology; D002392:Catechin / Q000031:analogs & derivatives* / Q000494:pharmacology; D002633:Chemotaxis; D004730:Endothelium, Vascular / Q000378:metabolism; D017313:Fenretinide / Q000494:pharmacology*; D005419:Flavonoids / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000517:prevention & control; D013662:Tea; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
chemical_list: D020533:Angiogenesis Inhibitors; D016588:Anticarcinogenic Agents; D000975:Antioxidants; D005419:Flavonoids; D013662:Tea; D042461:Vascular Endothelial Growth Factor A; D017313:Fenretinide; D002392:Catechin; C045651:epigallocatechin gallate; D000111:Acetylcysteine